NAMS EPS Estimates - NewAmsterdam Pharma Company N.V. logo

NAMS EPS Estimates

NewAmsterdam Pharma Company N.V.

$19.74
+$0.35(+1.81%)
39
Overall
50
Value
20
Tech
47
Quality
How is this score calculated?
Market Cap
$2.37B
Volume
1.80M
52W Range
$17.90 - $42.21
Target Price
$51.50

NAMS EPS estimates: the consensus estimate for NewAmsterdam Pharma Company N.V.'s current fiscal year is -$1.48 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

NAMS EPS Estimates

EPS estimate, current quarter
$-0.44
EPS estimate, next quarter
$-0.54
EPS estimate, current year
$-1.48
EPS estimate, next year
$-2.29
EPS growth, 3-year
-21.46%
NAMS reported EPS by year
Fiscal yearEPS
2025$-1.72
2024$-2.56
2023$-2.15
2022$-0.96
ABCD
1SymbolPriceChangeVol
2NAMS$19.74+1.8%1.80M
3
4
5
6

Get NewAmsterdam Pharma Company N.V. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.